×
About 7,308 results

ALLMedicine™ Tetanus Center

Research & Reviews  2,221 results

A school-based educational on-site vaccination intervention for adolescents in an urban...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744022
BMC Public Health; Bethke N, Gellert P et. al.

Jan 12th, 2022 - Vaccination rates for measles, mumps, and rubella (MMR) and diphtheria, tetanus, pertussis, and polio (Tdap-IPV) are not optimal among German adolescents. Education in combination with easy access to vaccination may be a promising approach to impr...

Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma
https://clinicaltrials.gov/ct2/show/NCT03361852

Jan 11th, 2022 - This research study is a Pilot Study, which is the first time investigators are examining the Personalized Neoantigen Vaccine (NeoVax) in patients diagnosed with follicular lymphoma. The FDA (the U.S. Food and Drug Administration) has not approved...

Fourteen years of the Pregnancy Registry on maternal immunisation with a reduced-antige...
https://doi.org/10.1016/j.vaccine.2021.12.050
Vaccine Kuznetsova A, Ceregido MA et. al.

Jan 8th, 2022 - GSK initiated a Pregnancy Registry in the United States (US) for the reduced-antigen-content tetanus-diphtheria-acellular pertussis (Tdap; Boostrix, GSK) vaccine with the aim to detect and describe pregnancy outcomes in women vaccinated with Boost...

Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregn...
https://doi.org/10.1080/21645515.2021.1915038
Human Vaccines & Immunotherapeutics; Switzer C, Tikhonov I et. al.

Dec 30th, 2021 - The "Adacel (Tdap5) Pregnancy Registry" was used to identify 1182 women who received the tetanus, diphtheria, acellular pertussis [5 components] (Tdap5) vaccine during pregnancy from 2005 to 2016. To evaluate the safety and use of prenatal Tdap5, ...

A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age
https://clinicaltrials.gov/ct2/show/NCT05169905

Dec 27th, 2021 - The purpose of this study is to evaluate the reactogenicity, safety and immune response of a single intramuscular dose of the respiratory syncytial virus maternal (RSV MAT) vaccine in healthy non-pregnant girls 9-17 years of age (YOA) compared to ...

see more →

Guidelines  12 results

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poli...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004397
MMWR. Morbidity and Mortality Weekly Report; Oliver SE, Moore KL

Feb 7th, 2020 - On December 21, 2018 the Food and Drug Administration (FDA) licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugate (meningo...

Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Upd...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367039
MMWR. Morbidity and Mortality Weekly Report; Havers FP, Moro PL et. al.

Jan 24th, 2020 - Since 2005, a single dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine has been recommended by the Advisory Committee on Immunization Practices (ACIP) for adolescents and adults (1,2). After receipt of Tdap,...

ACOG Committee Opinion No. 741 Summary: Maternal Immunization.
https://doi.org/10.1097/AOG.0000000000002665
Obstetrics and Gynecology;

May 26th, 2018 - Immunization is an essential part of care for adults, including pregnant women. Influenza vaccination for pregnant women is especially important because pregnant women who contract influenza are at greater risk of maternal morbidity and mortality ...

Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Re...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919600
MMWR. Recommendations and Reports : Morbidity and Mortali... Liang JL, Tiwari T et. al.

Apr 28th, 2018 - This report compiles and summarizes all recommendations from CDC's Advisory Committee on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria, and pertussis in the United States. As a comprehensive summary of previ...

Committee Opinion No. 718: Update on Immunization and Pregnancy: Tetanus, Diphtheria, a...
https://doi.org/10.1097/AOG.0000000000002301
Obstetrics and Gynecology;

Aug 24th, 2017 - The overwhelming majority of morbidity and mortality attributable to pertussis infection occurs in infants who are 3 months and younger. Infants do not begin their own vaccine series against pertussis until approximately 2 months of age. This leav...

see more →

Drugs  93 results see all →

Clinicaltrials.gov  126 results

Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma
https://clinicaltrials.gov/ct2/show/NCT03361852

Jan 11th, 2022 - This research study is a Pilot Study, which is the first time investigators are examining the Personalized Neoantigen Vaccine (NeoVax) in patients diagnosed with follicular lymphoma. The FDA (the U.S. Food and Drug Administration) has not approved...

A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age
https://clinicaltrials.gov/ct2/show/NCT05169905

Dec 27th, 2021 - The purpose of this study is to evaluate the reactogenicity, safety and immune response of a single intramuscular dose of the respiratory syncytial virus maternal (RSV MAT) vaccine in healthy non-pregnant girls 9-17 years of age (YOA) compared to ...

Healthy, Immunized Communities Study
https://clinicaltrials.gov/ct2/show/NCT03854734

Dec 21st, 2021 - Vaccines are considered one of the greatest public health successes. Unfortunately, an increasing rate of parental resistance in recent years has led to a reemergence of vaccine-preventable diseases. This project seeks to determine the effect of a...

Tdap Vaccine Safety for Plasma Donors
https://clinicaltrials.gov/ct2/show/NCT04142983

Dec 16th, 2021 - This is a prospective, open label, single-arm, multi-center, Phase 1 study measuring the safety and tetanus antibody responses to Tdap vaccine administered to plasma donors every 3 months ±1 week for 12 months (5 vaccinations) with a 6 month follo...

Long-Term PF-06651600 for the Treatment of Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT04006457

Dec 15th, 2021 - This is a global Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called PF-06651600) in adults and adolescents (12 years and older) who have alopecia areata. Eligible patients from the prior studies B793100...

see more →

News  463 results

What Do We Really Know About Vaccine Effectiveness?
https://www.medscape.com/viewarticle/962087

Nov 2nd, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The politicization of covid vaccines — and, well, just about everything else having to do with the pandemic — has led to confusion, if not utter f...

Venezuelan Academy of Medicine Expresses Concern Over Use of Cuban Vaccine
https://www.medscape.com/viewarticle/959799

Sep 28th, 2021 - CARACAS (Reuters) - Venezuela's National Academy of Medicine on Monday expressed concern over the use of Cuba's Abdala coronavirus vaccine due to a lack of scientific research on its safety and efficacy. Cuba said on Saturday it had exported the t...

Changing Minds: What Moves the Needle for the Unvaccinated?
https://www.medscape.com/viewarticle/958086

Sep 2nd, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Heather Simpson Not so long ago, Heather Simpson of Dallas was known as the anti-vaccine mom who dressed as "the measles" for Halloween. She paint...

Cuba Prepares to Vaccinate Its Children, Entire Population
https://www.medscape.com/viewarticle/957988

Sep 2nd, 2021 - HAVANA (Reuters) - Cuba will begin vaccinating adolescents against COVID-19 this week and younger children from mid-September as part of a drive to immunize more than 90% of the population by December, state-run media said on Wednesday. All childr...

COVID-19: Delta variant is raising the stakes
https://www.mdedge.com/psychiatry/article/243862/coronavirus-updates/covid-19-delta-variant-raising-stakes
Robert T. London, MD

Aug 3rd, 2021 - Like many colleagues, I have been working to change the minds and behaviors of acquaintances and patients who are opting to forgo a COVID vaccine. The large numbers of these unvaccinated Americans, combined with the surging Delta coronavirus varia.

see more →

Patient Education  8 results see all →